Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net income (loss)	$ 7,406	$ (5,052)
Adjustments to reconcile to net cash used in operating activities:
Depreciation and amortization	45,186	18,683
Amortization of debt issue costs	1,888	1,297
Extinguishment of debt	3,395	0
Stock-based compensation	2,448	0
Deferred income taxes	(2,406)	(3,999)
Change in fair value of earnout liability	483	0
Gain on sale of rental equipment	(3,632)	(2,055)
Bargain purchase option	0	(1,363)
Charge for step-up of acquired inventory	2,866	0
Net realizable value and reserve adjustment for obsolete and excess inventory	4,608	1,104
Bad debt expense	795	939
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(21,771)	6,936
Inventories	(42,404)	(5,059)
Prepaid expenses and other current assets	(1,874)	1,732
Accounts payable	(8,839)	(2,241)
Accrued expenses and other current liabilities	4,492	2,894
Other changes in operating assets and liabilities	(3,670)	(3,496)
Net cash provided by (used in) operating activities	(11,029)	10,320
Investing activities
Purchases of property, plant and equipment	(8,307)	(3,026)
Business acquisitions, net of cash acquired	(115,343)	(33,936)
Purchases of rental equipment	(11,794)	(10,755)
Proceeds from sale of rental equipment	8,756	6,341
Net cash provided by (used in) investing activities	(126,688)	(41,376)
Financing activities
Proceeds from revolving lines of credit	383,489	38,121
Payments on revolving lines of credit	(320,751)	(11,200)
Proceeds from term loans	445,630	6,000
Payments on term loans	(335,305)	(7,486)
Deferred financing costs	(11,956)	0
Capital contribution	0	9,233
Repurchase of common stock	(1,940)	0
Shares repurchased held in treasury	(520)	0
Payment of financing lease principal	(429)	0
Payment on seller's note	(9,757)	0
Net cash provided by (used in) financing activities	148,461	34,668
Effect of exchange rate changes on cash and cash equivalents	(675)	660
Increase (decrease) in cash, cash equivalents and restricted cash	10,069	4,272
Cash, cash equivalents and restricted cash at beginning of period	14,671	10,399
Cash, cash equivalents and restricted cash at end of period	24,740	14,671
Cash and cash equivalents	24,554	14,671
Restricted cash	186	0
Supplemental disclosure of cash flow information
Net cash paid for income taxes	13,813	2,998
Net cash paid for interest	22,153	15,395
Fair value of common stock exchanged for reverse acquisition	351,491	0
Settlement of related party obligations	5,276	0
Equity consideration in relation to business acquisitions	0	6,946
Seller's note issued as purchase consideration	$ 1,169	$ 8,357